logo of the vendor
Pharma Intelligence UK Ltd logo

Securing your samples: Strategies for safeguarding critical biological materials

thumbnail of content

To deliver these therapies to the patients who need them, their success hinges on effective storage and management to maintain integrity throughout their lifecycle.

From early development to commercialization, safeguarding sensitive biological materials demands scalable storage solutions and meticulous risk mitigation strategies. Partnering with a CDMO specializing in ultracold storage and biorepository management is critical to preserving product integrity and ensuring continuity throughout every development stage.

This webinar will explore how the right CDMO partner can streamline biological material storage, mitigate risks, and provide the scalability needed to support growth from clinical trials to commercial launch, empowering you to advance your pipeline with confidence.

Participants will gain insight into:

  • The complexities of biological material storage and how to mitigate associated risks
  • Scalable storage solutions that adapt to the needs of clinical and commercial stages
  • Risk management strategies to safeguard product integrity and ensure continuity
  • How expert biorepository services can support accelerated development timelines

Register for the Webinar

Opt In?

Please complete all required fields to access the content!

Explore similar content

IQVIA Technologies
Pharma Intelligence UK Ltd

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:
Article Clinical Studies Pharmaceutical Research and Development
Novotech
Pharma Intelligence UK Ltd

From biomarkers to regulatory compliance, and the impact of AI/ML

The field of precision medicine is rapidly evolving, enabling the development of innovative therapies highly tailored to individuals’ genetic profiles - resulting in revolutionized treatments and improved patient outcomes. Discover expert insights on the current landscape of personalized medicine, including the opportunities and challenges, including:
Report Clinical Studies Pharmaceutical Research and Development
Veeva
Pharma Intelligence UK Ltd

Explore expert strategies for standardizing document formats, aligning on terminology, and collaborating to improve quality and regulatory compliance in preparation for impending Quality Management System Regulation (QMSR) updates from US FDA.

Discover new insights into coordinating medtech quality processes and platforms to successfully achieve global quality and regulatory harmonization. Explore the considerations of harmonization and understand how it can help organizations comply with impending Quality Management System Regulation (QMSR) updates from the U.S. Food and Drug Administration (FDA). Read now to learn how medtech organizations can:
Article Clinical Studies Pharmaceutical Research and Development